The novel approach of this peptide represents a exciting advance in the care of type 2 diabetes. Different to existing medications, tirzepatide affects two pathways – GLP-1 and GIP – leading to greater blood sugar https://tirzepatide-peptide061117.targetblogs.com/42323483/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment